Table of Contents
Molecules, Volume 24, Issue 5 (March-1 2019)
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
- You may sign up for e-mail alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Cover Story (view full-size image) The race to develop glycosaminoglycan (GAG) mimetics as the drug of choice for ailments ranging [...] Read more. The race to develop glycosaminoglycan (GAG) mimetics as the drug of choice for ailments ranging from cancer to inflammation is heating up. The development of any new drug class, however, comes with challenges. Moving from animal models to clinical trials is an important step, and, often, the preclinical data do not translate well to the clinical setting. Increasingly, it is being understood that the choice of animal species used in preclinical testing is of critical importance. For GAG mimetics, making an informed choice has been difficult. However, we are now proposing a method based on a range of comparative modelling techniques that will transform this process. The application of our method should lead to data that better translate to the clinical stages, and, hence, reduce the risks of moving from preclinical to clinical trials. View this paper.